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Abstract
Background: Reliable and easy to administer screening instruments focusing on neurodevelopmental disorders
and associated conditions are scarce. The Autism–Tics, AD/HD and other Comorbidities inventory (A-TAC) has
previously been validated and reporting good– excellent validity for several disorders. This article aims to expand
these findings by including more conditions in a substantially larger sample augmented with the Swedish National
Patient Register (NPR).
Methods: Since 2004 parents of all 9-year-old Swedish twins have been invited to participate in a telephone
interview in the Child and Adolescent Twin Study in Sweden, CATSS. The CATSS is linked to the NPR which
includes data from in- and outpatient care. Data on neurodevelopmental disorders (A-TAC) collected in CATSS
were compared with diagnoses from the NPR. We investigated diagnoses that had been made both before
(previous validity) and after (predictive validity) the interview.
Results: Sensitivity and specificity of A-TAC scores for predicting earlier or later clinical diagnoses were mostly
good–excellent, with values of the area under the curve for a clinical diagnosis of autism spectrum disorder
(ASD) of .98, attention deficit hyperactivity disorder (ADHD) .93, learning disorder (LD) .92, and oppositional
defiant disorder (ODD) .99, with small differences in terms of previous and predictive analyses. A-TAC provided
little validity for eating disorders.
Conclusion: The result support previous claims: A-TAC is a broad screening instrument with a particular strength
in assessing ASD, ADHD, LD, and ODD at ages 9 and 12, and also provides phenotypic information about other
child psychiatric disorders.
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Background
Childhood-onset neuropsychiatric disorders, commonly
lumped together under the concept of neurodevelopmen-
tal disorders (NDDs), affect at least 7–10% of all children
[1]. They have traditionally been considered as distinct
and separate from each other, each with a course of its
own. However, the term Early Symptomatic Syndromes
Eliciting Neurodevelopmental Clinical Examinations
(ESSENCE) has been suggested in order to emphasize
the clinical reality of children as manifestations of one
or more major developmental symptoms before the age
of 5 often implies problems in the same or an overlap-
ping area later in life [1]. Today it is acknowledged that
NDDs share symptomatology [1, 2] follow a waxing and
waning course [3], and can be unstable within a diag-
nostic category over time [4, 5]. In addition, NDDs
share predisposing environmental and genetic factors
with each other [6], and are dimensionally distributed
in the population [7]. Taken together, validated screening
instruments that dimensionally assess the symptomatology
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of several NDDs simultaneously are therefore required
as a complement to the diagnostic interview in clinical
practice, but also in large-scale epidemiological studies
where diagnostic assessments are rarely feasible.
The Autism–Tics, AD/HD and other Comorbidities
inventory (A-TAC) was developed by three of the authors
(CG, MR, and HA) at the Department of Child and
Adolescent Psychiatry, forerunner of the Gillberg Neuro-
psychiatry Centre, at the University of Gothenburg. The
A-TAC is a broad-band screening instrument that encom-
passes autism spectrum disorder (ASD), attention deficit
hyperactivity disorder (ADHD), tic disorders (TD), devel-
opmental coordination disorder (DCD), and learning dis-
order (LD). Furthermore, the A-TAC also covers possible
overlapping childhood neuropsychiatric and/or psychiatric
disorders such as obsessive-compulsive disorder (OCD),
oppositional defiant disorder (ODD), conduct disorder
(CD), and eating disorders (ED). All disorders targeted in
the A-TAC have been subjected to validation studies on
children and adolescents: Three cross-sectional validation
studies [8–10] and one longitudinal [11]. Briefly, cross-
sectionally the A-TAC shows excellent inter-rater reliabil-
ity and good test-retest measures [8, 10]. The ASD and
ADHD modules have shown excellent screening proper-
ties in a clinical sample of children when compared to
diagnoses assigned during an investigation at a child
neuropsychiatric clinic [8]. These results were later repli-
cated by Larson et al. in a community based sample of
children, for ASD and ADHD the “low” cut-off value for
screening purposes reported a high sensitivity (above 0.95)
and the clinical proxy reported a high specificity (0.95) [9].
Cut-off scores for DCD, LD, and TD have also been estab-
lished in clinical as well as community samples [8, 9]. A
longitudinal three-year follow-up study of 452 individuals
showed that the A-TAC could be used as a predictive as-
sessment tool: the predictive validity was good to excellent
for ASD, ADHD, LDs, and TDs [11]. The A-TAC showed
convergent validity with the Child Behavior Checklist in
scales with related content, but also provided a more
specific assessment of ASDs, DCD, LD and tic disorders
[12]. In addition, the ASD module has been subjected to
an independent Spanish validation [13] where the psycho-
metric properties were reported to be excellent.
Even though the A-TAC can be considered to be
well-validated there are still some issues that need to be
addressed: (a) The number of cases in the longitudinal
validation study were limited as some NDDs were rare,
for instance the clinically assessed ASD-group consisted
of 20 individuals only. Conditions like CD and ODD
are overrepresented among non-responders, and were
not sufficiently represented in the validation studies. (b)
The onset of EDs are generally later than the assessed
ages [14], leading to an underrepresentation of this type
of disorders, why it has been difficult to establish the
predictive validity for these disorders. (c) Those who
participate in the clinical validation studies might differ
in their degree of symptomatology, dysfunction, and
suffering, compared to those who do not participate.
Therefore previous validation studies of the A-TAC
might not satisfactorily investigate the instruments eco-
logical validity.
A-TAC has been used in an ongoing nation-wide twin
study named the Child and Adolescent Twin Study in
Sweden (CATSS) that has been linked to the National
Patient Register (NPR). This makes it possible to,
among other things, study the validity of the A-TAC in
a population-based sample, and thus get even more re-
liable results for rare conditions, and in conditions
where non-responding is elevated. A distinction be-
tween previous and predictive validity was made. This
distinction was motivated by the fact that CATSS has
been ongoing for more than 10 years. During this time
differences in diagnostic practice, professional and public
awareness and referral patterns have most likely arisen.
For instance, the high cut-off for ASD has remained stable
for 10 years in CATSS while the officially recorded preva-
lence in NPR has increased substantially [15]. Further-
more, there is substantial evidence that secular changes in
practice are related to diagnostic substitution. Shattuck re-
ported a decreasing prevalence of learning disabilities and
intellectual disability in USA from 1994 to 2003 with an
equivalent increasing prevalence of ASD [16].
The aim of this study was to investigate the previous
and predictive validity of the A-TAC in a nation-wide
sample of twins where register-based diagnoses were
available.
Method
The Child and Adolescent Twin Study in Sweden (CATSS)
The CATSS is an ongoing longitudinal twin study
designed to assess somatic and mental health disorders
during childhood. The study has been described in
detail in an overview-article [17]. Briefly, since July
2004, parents of all Swedish 9-year-old twins (born 1st
July 1995 and onwards) were identified through the
Swedish Twin Registry and asked to participate in a
telephone interview. During the first three years of the
CATSS, 12-year-old twins (born July 1992–June 1995)
were also included. The rationale for choosing these
age groups were that most major childhood mental dis-
orders have emerged by then, while the normal prob-
lems of puberty have not. The CATSS has a response
rate of 75% with small differences between responders
and non-responders with regards to psychopharmaco-
logical treatment and socioeconomic status. In 87,5% of
the interviews the informant was the mother; 12,2% the
father, and for the remaining 0,3% another member of
the family [17].
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The Swedish National Patient Register (NPR)
All individuals who are born in Sweden or have received
a citizenship are given a personal identification number,
which is recorded in all contacts with health care, social-
and administrative services. The CATSS data was
merged with the NPR via the personal identification
number. The NPR includes information about all as-
cribed diagnoses in psychiatric inpatient care since 1987
[18]. Since 2001 the register also includes data from out-
patient consultations. The NPR consists of best-estimate
specialist diagnoses assigned according to the International
Classification of Diseases ninth (ICD-9) and tenth (ICD-10)
revision [19, 20]. The validity of data in the NPR is continu-
ously under assessment: A validation study, which included
NPR diagnoses, reported that 96% (confidence interval
92.0%–98.4%) of the listed ASD diagnoses could be con-
firmed through medical records [21]. Similarly the validity
of OCD and TD is reported to be high [22]. Data from the
NPR was available up until 31st of December 2012.
The population for which data from the NPR was ex-
tracted consisted of 25,828 twins (49% ♀), 19,322 9-year-
olds and 6,506 12-year-olds whose parents had responded
to the A-TAC. The clinicians who ascribed the diagnoses
in the NPR did not have any knowledge about the result
from the A-TAC interview.
Measures
The Autism–Tics, AD/HD and other Comorbidities inventory
(A-TAC)
The A-TAC is a collateral interview fully structured to
enable laymen to preform it over the telephone. It
consists of 96 items based on the diagnostic criteria in
the Diagnostic and Statistical Manual of Mental Disor-
ders, fourth edition (DSM-IV) [23], clinical experience
and relevant aspects or questions included in available
screening instruments in the field of NDD, such as the
Asperger Syndrome Screening Questionnaire [24], the
Asperger Syndrome Diagnostic Interview [25] and the
Five to Fifteen questionnaire [26].
The items are divided into 20 theoretically defined
modules: Motor Control; Perception; Concentration &
Attention; Impulsiveness & Activity; Learning; Planning
& Organizing; Memory; Language; Social Interaction;
Flexibility; Tics; Compulsions; Feeding; Separations;
Opposition; Conduct; Anxiety; Mood; Concept of Real-
ity; and Miscellaneous (i.e. clinically specific problems
that are not covered by the other modules such as sleep,
food fads, severe overweight, bodily functions, and sub-
stance abuse). Each module is assessed without taking
diagnostic exclusion or hierarchies into account. The
items are assessed in a “whole-life” frame and are coded
on a dimensional scale where each item has three
response categories:” No” scored as 0,” Yes, to some
extent” scored as 0.5, and” Yes” scored as 1. The A-TAC
has an average administration time of ≈ 27.5 min and is
frequently used in clinical practice [10]. It is an open
access instrument that is available in Swedish and
English and can be downloaded from the Gillberg
Neuropsychiatry Centre website [27] and is also available
as an appendix in Larson et al. [9].
Definition of disorders
A-TAC
Each A-TAC module corresponds to a diagnostic domain,
except the ASD and ADHD domains, which include
several modules. In Table 1 the A-TAC modules, total
number of items, previously reported internal consistency
as well as sensitivity and specificity for each established
cut-off value are presented. For ASD, ADHD, LD, and
DCD, two cut-off values have been created: a “low” cut-off
with high sensitivity for broad screening purposes and a
“high” cut-off with a high specificity to use as a clinical
proxy in research settings [9]. For ODD and CD clinical
proxies has been created [28]. No validation has been con-
ducted for the OCD and ED-modules.
NPR
From the NPR, diagnostic data were obtained by search-
ing for ICD-9 and ICD-10 codes to the corresponding
conditions. If only one diagnostic code is presented, it in-
cludes all types subsumed under that code. ASD (ICD-9:
299.0, 299.8, 299.9, ICD-10: F84.0, F84.1, F84.5, F84.9),
ADHD (ICD-9: 314, ICD-10: F90), LD (ICD-9: 317–319,
ICD-10: F70-F79), DCD (ICD-9: 315.4, ICD-10: F82), TD
(ICD-9: 307.2, ICD-10: F95), ODD (ICD-9: 313.8, ICD-10:
F91.3), CD (ICD-9: 312, ICD-10: F91, excluding F91.3),
OCD (ICD-9: 300.3, ICD-10: F42), ED (ICD-9: 307.1,
307.50, 307.51, ICD-10: F50).
Statistical analysis
The sample was divided into two different groups based
on age when the first diagnosis was listed in the NPR: (1)
before (previous) or (2) after (predictive) the A-TAC inter-
view. The previous-group also included twins who had the
first diagnosis registered the same year as the A-TAC
interview. The analyses were also conducted in a collapsed
fashion, including the whole sample. Since the CATSS
included 12 year-old twins the first three years, calcula-
tions based on the A-TAC were also stratified by age.
Receiver operating characteristics (ROC) was used in
order to illustrate the area under the curve (AUC) for
the different scale steps. The AUC is a measure of how
good the instrument can discriminate between false pos-
itives and true positives on a binary classifier (diagnosis)
for all possible values on a continuous scale and provides
information about the sensitivity and specificity for each
scale step. An AUC equal to 0.50 indicate random predic-
tion, 0.60–0.70 poor validity, 0.70–0.80 is fair, 0.80–0.90 is
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good and an AUC > 0.90 signals excellent validity [29].
The scales from A-TAC were used as independent predic-
tors and the clinical diagnoses from the NPR were used as
dependent variables.
Each cut-off value was examined by measures of sensi-
tivity (sens), specificity (spec), positive predictive value
(PPV) and negative predictive value (NPV). Sensitivity is
defined as the proportion of subjects with a true disorder
who are identified as screen-positives while specificity
defines the proportion of subjects without a disorder who
are identified as screen-negatives. The predictive values,
PPV and NPV, are dependent on the prevalence of a dis-
order. PPV describes the probability that a positive predic-
tion is correct and NPV the probability that a negative
prediction is correct [30, 31].
In order to interpret the results irrespective of base rates
and the “false positive paradox” (i.e., when the false-
positive rate is higher than the actual prevalence of the
studied condition) we included the diagnostic odds ratio
(DOR) which is defined as the ratio of odds of a screen-
positive result for a subject with a true disorder relative to
the odds of a screen-positive result for a non-afflicted sub-
ject. The DOR value ranges from zero to infinity and
higher DOR values suggest a better discriminatory test
performance, and is such a helpful tool when deciding
how accurate a diagnostic test is and how it compares to
other tests [30, 32].
All statistical analyses were performed in the SPSS
software package, version 22.0.
Ethical considerations
Informed consent was obtained from all parents. The
data collection in the CATSS, and the linkage to the
NPR has ethical approval from the Karolinska Institute
ethical review board (Dnr 02–289 and 2010/507–31/1).
Results
The prevalence of the diagnoses according to the NPR
and the number of subjects with an A-TAC score equal to
or higher than each cut-off value are presented in Table 2.
The previous and predictive validities of the A-TAC are
reported in Table 3. The previous validity for ASD was ex-
cellent (AUC = 0.98). The screening cut-off showed a high
sensitivity (0.85) and the clinical proxy had a high specifi-
city (0.99). The NPV was high (0.999 and 0.997 respect-
ively), the clinical proxy had a higher PPV (0.22) while the
screening cut-off had a higher DOR (166). The LD module
reported an excellent predictive validity (AUC= 0.92). The
screening cut-off showed a higher sensitivity (0.89) than
specificity (0.85) and the clinical proxy had a high specifi-
city (0.99) but a considerably lower sensitivity (0.40). The
NPV was high (0.999 and 0.998 respectively) while the
PPV was low for both cut-off values (0.02 and 0.1), the
screening cut-off showed the highest DOR value (48).
Table 1 The A-TAC Modules: Previously Reported Internal Consistency and Sensitivity/Specificity for each Established Cut-off Value
Diagnostic domain A-TAC module Items Cronbach’s α Cut-off sens/spec
ASD Language, Social Interaction 17 .86b 4.5 (low) 0.91/0.80c
and Flexibility 8.5 (high) 0.61/0.91c
- Language 6 .66b
- Social Interaction 6 .77b
- Flexibility 5 .70b
ADHD Concentration & Attention and 19 .92b 6 (low) 0.91/0.73
Impulsiveness & Activity 12.5 (high) 0.56/0.93c
- Concentration & Attention 9 .90b
- Impulsiveness & Activity 10 .87b
LD Learning 3 1 (low) 0.92/0.60c
3 (high) 0.41/0.93c
DCD Motor control 1 0.5 (low) 0.63/0.68c
1 (high) 0.32/0.87c
TD Tics 3 .57b 1.5 0.875/0.86c
ODD Opposition 5 .75b 3 0.51/0.96d
CD Conduct 5 .61b 2 0.55/0.98d
OCDa Compulsions 2 1
EDa Feeding 2 1
aNo previous established cut-off value
bAnckarsäter et al., 2011
cLarson et al., 2010
dKerekes et al., 2014
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The results for the age-specific groups, i.e. 9- respect-
ive 12-year-olds, are available as supplementary material
(Additional file 3). These results showed a similar pat-
tern as the collapsed group with the only exception for
the OCD module for the 12-year olds which displayed
an excellent predictive validity (AUC = 0.99) with an ex-
cellent sensitivity (1.0) and specificity (0.98).
Discussion
The purpose of this study was to examine the previous
and predictive validity of the A-TAC inventory in a
nation-wide sample of twins. The findings in this study
support previous claims: A-TAC has a particular
strength in assessing ASD, ADHD, LD, and ODD at ages
9 and 12, and also provides phenotypic information
about other child psychiatric disorders. A-TAC has the
ability to identify subjects without NPD, which is valu-
able in epidemiological research and in case-control
studies. In clinical practice, the “low” cut-off values
should be used in order to get an initial assessment that
makes it possible to directly focus on the child’s most
predominant symptoms and behavioral problems.
The results suggest that the A-TAC has good validity
for previously made diagnoses while its predictive valid-
ity (with the exception of LDs) is not as good. This, pos-
sibly, reflects the fact that parents of already diagnosed
children had knowledge about the disorders in question
and thus were better able to recognize the symptoms
that were asked about during the telephone interview.
Future studies using the A-TAC should take this dis-
crepancy into account. Nevertheless, given the difference
Table 2 Subjects With a Listed Disorder in the NPR (%) and
Screen-positives in A-TAC (%)
Disorder in the NPR A-TAC
Disorder Before After Total Cut-off Screen-positive
ASD 127 (0.5) 171 (0.7) 298 (1.2) 4.5 924 (3.6)
8.5 266 (1.0)
ADHD 231 (0.9) 492 (1.9) 723 (2.8) 6 2707 (10.5)
12.5 524 (2.0)
LD 145 (0.6) 104 (0.4) 249 (1.0) 1 3961 (15.3)
3 428 (1.7)
DCD 70 (0.3) 18 (0.1) 88 (0.3) 0.5 2050 (7.9)
1 469 (1.8)
TD 41 (0.2) 47 (0.2) 88 (0.3) 1.5 847 (3.3)
ODD 8 (0.0) 20 (0.1) 28 (0.1) 3 795 (3.1)
CD 27 (0.1) 50 (0.2) 77 (0.3) 2 278 (1.1)
OCDa 9 (0.0) 61 (0.2) 70 (0.3) 1 479 (1.9)
EDa 32 (0.1) 127 (0.5) 159 (0.6) 1 1371 (5.4)
N = 25,828
Disorder in NPR: Ascribed diagnoses in NPR before and after the telephone
interview (CATSS) and in total
A-TAC: Number of screen-positive subjects with an A-TAC score equal to or
higher than each cut-off value
Please see the supplementary material for numbers of true positive, false
positive, true negative and false negative for all disorders (Additional file 1),
and the sensitivity and specificity for each point on ASD and ADHD scale
(Additional file 2)
aNo previous established cut-off value
Table 3 Previous and Predictive Validity of A-TAC
Disorder Cut-off Previous Predictive Total
AUC sens/spec PPV NPVb DOR AUC sens/spec PPV NPVb DOR AUC sens/spec PPV NPVb DOR
ASD 4.5 (low) 0.98 0.85/0.97 0.11 0.999 166 0.81 0.42/0.97 0.08 0.996 21 0.89 0.60/0.97 0.19 0.995 49
8.5 (high) 0.48/0.99 0.22 0.997 113 0.17/0.99 0.11 0.995 22 0.30/0.99 0.33 0.992 62
ADHD 6 (low) 0.93 0.79/0.90 0.07 0.998 34 0.82 0.56/0.90 0.10 0.991 12 0.86 0.64/0.91 0.17 0.989 18
12.5 (high) 0.46/0.98 0.2 0.995 50 0.19/0.98 0.18 0.984 14 0.28/0.99 0.38 0.979 29
LD 1 (low) 0.87 0.83/0.85 0.03 0.999 27 0.92 0.89/0.85 0.02 0.999 48 0.89 0.86/0.85 0.05 0.998 34
3 (high) 0.37/0.99 0.13 0.996 40 0.40/0.99 0.1 0.998 44 0.39/0.99 0.22 0.994 48
DCD 0.5 (low) 0.82 0.70/0.92 0.02 0.999 27 0.57 0.22/0.92 0 0.999 3 0.77 0.60/0.92 0.03 0.999 18
1 (high) 0.38/0.98 0.06 0.998 35 0.11/0.98 0 0.999 7 0.32/0.98 0.06 0.998 27
TD 1.5 0.86 0.59/0.97 0.03 0.999 43 0.80 0.47/0.97 0.03 0.999 27 0.83 0.52/0.97 0.05 0.998 34
ODD 3 0.99 0.88/0.97 0.01 1.0 222 0.80 0.45/0.97 0.01 1.0 26 0.85 0.57/0.97 0.02 1.0 43
CD 2 0.90 0.52/0.99 0.05 0.999 104 0.70 0.20/0.99 0.04 0.998 24 0.77 0.31/0.99 0.09 0.998 45
OCDa 1 0.88 0.67/0.98 0.01 1.0 107 0.65 0.25/0.98 0.03 0.998 18 0.68 0.30/0.98 0.04 0.998 24
EDa 1 0.72 0.38/0.95 0.01 0.999 11 0.52 0.10/0.95 0.01 0.995 2 0.56 0.16/0.95 0.02 0.995 3
Previous and predictive validity: area under the curve (AUC), sensitivity/specificity, positive (PPV) and negative predictive value (NPV), and diagnostic odds
ratio (DOR) for each cut-off value in the A-TAC
aNo previous established cut-off value
bFor clarity reasons, NPV is reported with three decimals
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in AUCs between the “previous” and “predictive” groups
it cannot be ruled out that the age of a given diagnosis
indicate a difference in the studied phenotype. ASD and
ADHD diagnosed in adolescence may differ on a num-
ber of features compared to traditional view, especially
considering the rising prevalences in Sweden [33]. That
is, the impact of the disorder on psychological abilities
and adaptive behavior might differ in severity and extent
so that treatment seeking is postponed until several
years after the age of nine. Information derived from the
A-TAC for other age-groups than 9 and 12 years may
also be less reliable and adhere to different cutoffs than
those proposed here. Particular attention is warranted in
the case of individuals aged >12 when features “typical”
of adolescence and puberty, rather than neurodevelop-
mental disorders, may influence the rating. Furthermore,
for teenagers in clinical settings the low sensitivity of the
ASD low cut-off (.42) argues against its use as an instru-
ment to select out those who need further assessments.
Future research should include the exploration of age-
and gender specific cutoffs so that psychometric proper-
ties of the A-TAC would be available, and also more spe-
cific, for different groups. For instance, for OCD the
mean age of onset has been reported to be 11.1 years
[34], which becomes evident as excellent previous valid-
ity for individuals aged 12 was reported, but not for
those assessed at age 9.
A-TACs dimensionality and together with its broad
encompassing of several neurodevelopmental disorders
can aid in research as well as in clinical settings. When
considering assessment and treatment of neurodevelop-
mental disorders, the co-existence of ‘other’ disorders is
essential. For instance, ASD in itself may not confer an in-
creased risk for negative outcomes [35], but coexisting dis-
orders, including ADHD, learning disabilities, language
disorder, tic disorders and other disorders (and combina-
tions of these) may be the real mediators when it comes to
negative outcomes [35–37]. Furthermore, in addition to
studying the effects of categorical diagnoses, there is a need
to include continuous measures of NDPs [38], the rationale
being that neurodevelopmental disorders tend to oscillate
above and below the diagnostic threshold. It is also unclear
how the presence of subthreshold traits from one category
influences the prognosis of individuals with ‘another’
disorder should be considered.
The present study has several strengths, including a
large population-based sample, a long follow-up time (i.e.
20 years for those born 1992), a high response rate and
linkage to a national patient register of good quality. How-
ever, there are also some limitations to this study that war-
rant discussion. The main limitation consists of the
diagnostic categories with a low number of individuals (≤
1%), i.e. DCD, TD, ODD, CD, OCD and ED, which may
yield uncertainties about the observed result. The reason
for the low prevalence of these disorders in the NPR is un-
known, but clinicians may prefer to assign a principal
diagnosis without any secondary diagnoses. For instance,
clinicians might “expand” the ADHD symptomatology to
include ODD and CD symptoms or the ASD symptom-
atology to include DCD. Furthermore, it has been argued
that twins differ from singletons and that twins may not
be representative of the general population in terms of
neurodevelopmental disorders. It has also been suggested
that twinning could increase the risk of developing ASD
[39, 40]. However, this notion has not been confirmed in
large population-based studies [15, 41]. Also, studies of
general psychiatric outcomes in twins, such as psychotic
and affective disorders, have found no or small differences
between twins and singletons [42–44].
Conclusions
The A-TAC showed good to excellent validity for a ma-
jority of the studied diagnoses, both in previous and pre-
dictive data, and is a suitable screening tool for a wide
range of NDDs at ages 9 and 12.
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